Smith & Nephew (LON:SN) Hits New 52-Week High – Here’s What Happened

Smith & Nephew plc (LON:SN) shares reached a new 52-week high on Friday . The stock traded as high as GBX 1,255.77 and last traded at GBX 1,242, with a volume of 3248581 shares traded. The stock had previously closed at GBX 1,213.50.

Analyst Upgrades and Downgrades

SN has been the topic of a number of recent analyst reports. Panmure Gordon restated a “hold” rating and issued a GBX 1,200 price target on shares of Smith & Nephew in a research report on Tuesday, December 9th. Royal Bank Of Canada downgraded Smith & Nephew to a “sector perform” rating and cut their price objective for the company from GBX 1,700 to GBX 1,350 in a research report on Wednesday, December 17th. Berenberg Bank reissued a “hold” rating and issued a GBX 1,300 price objective on shares of Smith & Nephew in a research note on Friday, January 23rd. JPMorgan Chase & Co. restated an “overweight” rating on shares of Smith & Nephew in a research note on Friday, November 7th. Finally, Citigroup lifted their price target on Smith & Nephew from GBX 1,450 to GBX 1,600 and gave the company a “buy” rating in a report on Friday, October 31st. Two investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of GBX 1,381.33.

Smith & Nephew Stock Performance

The firm has a market cap of £13.62 billion, a P/E ratio of 44.72, a PEG ratio of 0.46 and a beta of 0.62. The company has a quick ratio of 0.84, a current ratio of 2.51 and a debt-to-equity ratio of 70.22. The firm has a fifty day moving average of GBX 1,234.78 and a 200-day moving average of GBX 1,287.49.

Insiders Place Their Bets

In other Smith & Nephew news, insider Deepak Nath sold 1,240 shares of the firm’s stock in a transaction that occurred on Tuesday, November 11th. The shares were sold at an average price of GBX 1,257, for a total value of £15,586.80. 0.19% of the stock is owned by corporate insiders.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.